Evidence map›Paper›PMID 29573576›Full record

ArticleMolecular genetics & genomic medicine2018

Toward clinical and molecular understanding of pathogenic variants in the ZBTB18 gene.

Vyne van der Schoot, Sonja de Munnik, Hanka Venselaar, Mariet Elting, Grazia M S Mancini, Conny M A Ravenswaaij-Arts, Britt-Marie Anderlid, Han G Brunner, Servi J C Stevens

Abstract read
In one paragraph

Article in Molecular genetics & genomic medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Identification of De NovoInternational journal of pediatrics · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Case Report: Identification of aFrontiers in genetics · 2021
    Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Vyne van der SchootDepartment of Clinical Genetics, Maastricht University Medical Centre, Maastricht, the Netherlands.ORCID 0000-0001-9829-9220
Sonja de MunnikDepartment of Human Genetics, Radboud University Medical Centre Nijmegen, Nijmegen, the Netherlands.
Hanka VenselaarCentre for Molecular and Biomolecular Informatics (CMBI), Radboud University Medical Centre Nijmegen, Nijmegen, the Netherlands.
Mariet EltingDepartment of Clinical Genetics, Vrije Universiteit, Amsterdam, the Netherlands.
Grazia M S ManciniDepartment of Clinical Genetics, Erasmus MC University Medical Centre, Rotterdam, the Netherlands.
Conny M A Ravenswaaij-ArtsUniversity of Groningen, University Medical Centre Groningen, Department of Genetics, Groningen, the Netherlands.
Britt-Marie AnderlidDepartment of Clinical Genetics, Karolinska Universitetssjukhuset, Solna, Sweden.
Han G BrunnerDepartment of Clinical Genetics, Maastricht University Medical Centre, Maastricht, the Netherlands.
Servi J C StevensDepartment of Clinical Genetics, Maastricht University Medical Centre, Maastricht, the Netherlands.ORCID 0000-0001-8769-3150

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPatients with pathogenic variants in ZBTB18 present with Intellectual Disability (ID) with frequent co-occurrence of corpus callosum (CC) anomalies, hypotonia, microcephaly, growth problems and variable facial dysmorphologies. These features illustrate a key role for ZBTB18 in brain development.

methodsPatients with a pathogenic variant in ZBTB18 were detected by diagnostic whole exome sequencing (WES) performed in our center. We reviewed the literature and used GeneMatcher to include other cases. YASARA and WHAT IF were used to provide insight into the structural effect of missense variants located in the C2H2 zinc finger domains of the ZBTB18 protein.

resultsWe give a complete overview of pathogenic variants in ZBTB18 detected to date, showing inconsistent presence of clinical features, including CC anomalies. We present four new cases with a de novo pathogenic variant in the ZBTB18 gene, including the fourth case in which a de novo p.Arg464His variant was found.

conclusionHomology modeling of protein structure points to a variable degree of impaired DNA binding caused by missense variants in these domains probably leading to Loss of Function (LoF). Putative partial LoF may present with a less distinctive phenotype than complete LoF, as seen in truncating variants, which presents with an extensive variability in the phenotypic spectrum. Our data do not support a clear genotype to phenotype correlation.

Indexed as

AdolescentAgenesis of Corpus CallosumBrainChildChild, PreschoolChromosome DeletionCorpus CallosumDevelopmental DisabilitiesDNA-Binding ProteinsExome SequencingFemaleGenetic Association StudiesHumansInfantIntellectual DisabilityMaleDNA-Binding ProteinsRepressor ProteinsZBTB18 protein, humanC2H2zinc finger (ZNF) domaincorpus callosum anomalieshomology modelingintellectual disabilityZBTB18

Identifiers

PMID29573576
PMCPMC6014478

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.